Advocate for women’s health and wellness. Authoritative expertise in healthcare laws and regulations. Experienced in solutions and structures.

Delphine O’Rourke has tackled some of the most difficult problems in healthcare from the C-suite and board rooms of health companies. She is a partner in the firm’s Life Sciences group, a member of the Corporate Social Responsibility (CSR), Environmental, Social and Governance (ESG) and Social Impact Investing groups, a health law subject matter expert, and provides strategic guidance, technical expertise and regulatory counsel to clients.

Ms. O’Rourke develops and executes regulatory solutions on behalf of entrepreneurs, growth companies, healthcare systems, public companies and investors, and works directly with leadership to leverage her clients’ innovative solutions. She focuses her healthcare regulatory practice on compliance with federal laws and regulations governing access, delivery and payment for medical care in the United States including EMTALA, the federal Anti-Kickback Statute, Stark Law, patient care issues, licensure, accreditation and tax exemption. Additionally, Ms. O’Rourke is a fierce advocate for founders in women’s health and partners with them along their journey by providing them with critical strategic and legal advice.

In addition to being a trusted and invaluable advisor for companies transforming the health and wellness industry, Ms. O’Rourke is an experienced health system leader and in-house counsel. Ms. O’Rourke was Associate General Counsel of Ascension, one of the largest private healthcare systems in the U.S., and now bridges the traditional health system for her clients’ products, services and investments.

Ms. O’Rourke serves on the boards of the Columbia Law School Alumni Association, The Forum of Executive Women, and The Foundation of The Forum of Executive Women. She is Vice-Chair of the Women’s Leadership Council of the American Health Law Association, member of CHIEF (a private network focused on connecting and supporting women leaders), healthcare expert for Endeavor (the world’s leading community of high-impact entrepreneurs) and Fellows Mentor for Summit Impact (a community-powered approach to scaling global impact).

Experience

ERFAHRUNG

EXPÉRIENCE

工作经历

Healthcare Providers

  • Serve as outside healthcare regulatory and contracting counsel for service providers, digital health companies, and supply chain vendors in transactions with health systems, academic medical centers and hospitals

  • Advise women’s health and wellness clients including entrepreneurs, growth and mature clients on critical regulatory issues including, and not limited to, remote provision of healthcare, friendly PC models, prohibition on fee-splitting, changes of ownership, government payor requirements, corporate compliance, patient issues, partnerships and contractual arrangements, value-based contracting, private payor arrangements, licensing, accrediting and enterprise risk management

  • Advise a variety of healthcare providers on compliance with the Anti-Kickback Statute, the Stark Law, OIG civil monetary penalties law, and state fraud and abuse provisions

Private Equity

  • Serve as outside counsel to private equity firms regarding portfolio companies, acquisitions of additional assets, and healthcare regulatory due diligence in connection with transactions

  • Provide corporate and healthcare regulatory counsel to private equity clients in connection with formations and investments in healthcare investment funds

  • Advise private equity companies regarding reimbursement strategies, Medicare and Medicaid requirements, corporate compliance, corporate practice of medicine and “friendly” PC structures

  • Provide healthcare reimbursement advice and counsel to private equity clients investing in healthcare providers, health services and medical devices

Digital Health

  • Serve as outside counsel on telemedicine, fraud and abuse and corporate laws to a variety of digital health companies including in the women’s health and wellness industry

  • Develop national growth legal strategies for telemedicine and tele-prescribing companies including counseling on multi-state telemedicine requirements, compliance plans, professional licensing, cross-state medical practice, Medicare and Medicaid reimbursement, physician-patient relationships, tele prescribing frameworks, fraud and abuse, and confidentiality

  • Provide ongoing healthcare regulatory counsel, including fraud and abuse, reimbursement, and privacy, to artificial intelligence and clinical decision platforms in a variety of different sub-industries

Healthcare Regulatory for Life Sciences Companies

  • Advising Achilles Therapeutics, a clinical-stage biopharmaceutical company developing precision T cell therapies for the treatment of cancer, on its $175.5 million initial public offering

  • Advising Autolus Therapeutics plc, a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer, on its $115 million follow-on offering

  • Advising the underwriters in Sensei Biotherapeutics, a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of the next generation of immunotherapies for the treatment of cancer and infectious diseases, on its $133 million initial public offering

  • Advising Kingswood Capital Management, LP, a private investment firm primarily focused on investing in businesses in transition, in connection with its acquisition of Cost Plus World Market from Bed Bath and Beyond Inc.

  • Advising Collective Medical Technologies, a real-time care collaboration network used by payors and healthcare organizations to improve patient outcomes, in connection with its sale to PointClickCare Corp. for approximately $600 million

  • Advising the Special Committee of the Board of Directors of NantKwest in connection with the company’s agreement to merge with ImmunityBio in a stock-for-stock transaction

  • Advising Achilles Therapeutics, a biopharmaceutical company developing personalized cancer immunotherapies, on the completion of its £52.7 million Series C

  • Advising a clinical-stage biotechnology company advancing new immunometabolic therapies for cancer in a Series B Preferred Stock financing

  • Advising a growth equity investment group in connection with the purchase of Series B Preferred Stock of a pre-clinical life sciences company studying the proteins that drive cancer and other diseases
Professional Activities

Ms. O’Rourke is an adjunct faculty member at Villanova Law School teaching healthcare and the law. 

Ms. O’Rourke is a member of the American Bar Association, American Health Lawyers Association, where she serves as Vice Chair of the Women’s Leadership Committee, as well as the New York and Pennsylvania State Bar Associations.

She is also an active member of her community serving as Board Member of the Columbia Law School Alumni Association, and Board Member and Chair of the Women in Leadership Committee of The Forum of Executive Women.

Professional Experience

Ms. O’Rourke spent over a decade of dedication in legal and executive roles with Ascension, the second largest healthcare system and largest nonprofit health system in the U.S. and the largest Catholic health system in the world.

In The News

MELDUNGEN

ACTUALITÉS

相关新闻

Credentials

WERDEGANG

RÉFÉRENCES

专业资格

Education

J.D., 2001
Columbia University
(Harlan Fiske Stone Scholar)
B.S., 1996
Georgetown University
(cum laude)

Clerkships

2002 U.S. District Court for the Eastern District of Pennsylvania, Honorable Legrome D. Davis

Admissions

Bar

Pennsylvania
New York
New Jersey

Courts

U.S. Supreme Court
U.S. District Court for the Southern District of New York
Profile Image
Get In Touch
Kontakt
NOUS CONTACTER
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
Recherche par Pratique
搜寻其他律师